A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(20 sites)

United States

Retinal Consultants Medical Group, Modesto, California

Retina Consultants of Southern California, Redlands, California

Retinal Consultants Medical Group, Sacramento, California

Retina Group of Florida, Fort Lauderdale, Florida

Fort Lauderdale Eye Institute, Plantation, Florida

Retina Vitreous Associates of Florida, St. Petersburg, Florida

Cumberland Valley Retina Consultants, Hagerstown, Maryland

Foundation for Vision Research, Grand Rapids, Michigan

Mississippi Retina Associates, Madison, Mississippi

ong Island Vitreoretinal Consultants / Vitreoretinal Consultants of NY, Hauppauge, New York

Retina Vitreous Surgeons of CNY, PC, Liverpool, New York

Charleston Neuroscience Institute - Bluffton, Bluffton, South Carolina

Charleston Neuroscience Institute, Charleston, South Carolina

Retina Research Institute of Texas, Abilene, Texas

Austin Retina Associates, Austin, Texas

Texas Retina, Plano, Texas

Retina Consultants of Texas, The Woodlands, Texas

Piedmont Eye Center, Lynchburg, Virginia

Pacific Northwest Retina, Burlington, Washington